PureTech Health (NASDAQ:PRTC) Stock Price Up 2.5% – What’s Next?

PureTech Health plc (NASDAQ:PRTC) shares rose 2.5% during mid-day trading on Monday . The company traded as high as $18.53 and last traded at $18.25. Approximately 3,307 shares changed hands during trading, an increase of 30% from the average daily volume of 2,553 shares. The stock had previously closed at $17.80.

PureTech Health Trading Up 2.5 %

The stock has a 50-day moving average price of $18.55 and a 200-day moving average price of $20.20.

Institutional Trading of PureTech Health

A hedge fund recently bought a new stake in PureTech Health stock. Birch Hill Investment Advisors LLC purchased a new stake in shares of PureTech Health plc (NASDAQ:PRTC) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 302,000 shares of the company’s stock, valued at approximately $5,575,000. Birch Hill Investment Advisors LLC owned about 1.26% of PureTech Health at the end of the most recent quarter. 0.04% of the stock is currently owned by hedge funds and other institutional investors.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.